Miist Therapeutics Announces $7M In Funding to Develop Instant-Acting Medicine
February 05, 2025 12:27 PM Eastern Standard Time ALAMEDA, Calif.–(BUSINESS WIRE)–Miist Therapeutics, a physics-based developer of inhaled medicines, today announced $7M in seed funding from investors including Refactor Capital, 1517 Fund, Freeflow Ventures, Entrepreneur First,…